Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results

Stock Information for Soliton Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Soliton Inc.

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Cidara Therapeutics to Participate in November Investor Conferences
Cidara Therapeutics to Report Third Quarter 2025 Financial Results and Host Quarterly Conference Call on November 6, 2025
Cidara Therapeutics Announces Late-Breaking Presentation on CD388 at 10?? ESWI Influenza Conference 2025
Cidara Therapeutics Announces Late-Breaking Phase 2b Data Presentation on CD388 at ID Week 2025
Cidara Therapeutics to Present Late-Breaking Clinical Phase 2 Data on CD388 at ID Week 2025
Cidara Therapeutics to Present at 10th ESWI Influenza Conference 2025
Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.